NCT00068757 2012-09-12Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast CancerEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 1 Completed23 enrolled